Gorham-Stout disease (GSD) has also been studied in the iLECKRAS mouse model using Prox1-CreERT2 to drive LEC-specific expression of KRAS (G12D), after an activating somatic variant in KRAS (G12V) was identified in one individual with GSD (24). Here, KRAS is linked to disorder of glycogen metabolism.